Case Report: Sustained Remission Due to PD-1-Inhibition in a Metastatic Melanoma Patient With Depleted B Cells

INTRODUCTION: Checkpoint-Inhibition (CPI) with PD-1- and PD-L1-inhibitors is a well-established therapy for advanced stage melanoma patients. CPI mainly acts via T-lymphocytes. However, recent literature suggests also a role for B cells modulating its efficacy and tolerability of CPI. CASE REPORT: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Wulfken, Lena Margarethe, Becker, Jürgen Christian, Hayajneh, Rami, Wagner, Annette Doris, Schaper-Gerhardt, Katrin, Flatt, Nina, Grimmelmann, Imke, Gutzmer, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525286/
https://www.ncbi.nlm.nih.gov/pubmed/34675925
http://dx.doi.org/10.3389/fimmu.2021.733961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525286/
https://www.ncbi.nlm.nih.gov/pubmed/34675925
http://dx.doi.org/10.3389/fimmu.2021.733961

Ejemplares similares